Ironwood

Ironwood's bowel disease treatment meets main goal in late-stage trial
Reuters
Thu, 02/29/24 - 11:02 am
Ironwood
chronic intestinal failure
clinical trials
short bowel syndrome
apraglutide
Ironwood's former pipeline spinout hits another speed bump, laying off 45% and turning toward the mitochondria
Endpoints
Thu, 10/6/22 - 10:57 am
Cyclerion
Ironwood
layoffs
mitochondrial disorders
Ironwood, AbbVie add 'bloating' and 'discomfort' to Linzess label to reach more IBS-C patients
Fierce Pharma
Fri, 10/9/20 - 10:55 am
Ironwood
AbbVie
Linzess
IBS-C
FDA
Linzess Receives Additional Indication in Japan for Chronic Constipation
CP Wire
Tue, 08/21/18 - 10:05 am
Linzess
Astellas
Ironwood
chronic constipation
Blockbuster dreams quashed, Ironwood drops AstraZeneca’s $1.3B gout drug disaster
Endpoints
Mon, 08/6/18 - 09:53 am
AstraZeneca
gout
lesinurad
Ironwood
Under pressure, Peter Hecht splits Ironwood into two biotechs, spinning out an R&D operation
Endpoints
Tue, 05/1/18 - 11:13 am
Ironwood
Peter Hecht
reorganization
Ironwood looks to boost gout franchise as FDA delivers OK for Duzallo
Endpoints
Mon, 08/21/17 - 09:40 am
Ironwood
gout
FDA
Duzallo
Ironwood claims a blockbuster success for its heartburn drug, but questions linger
Endpoints
Thu, 07/20/17 - 11:17 am
Ironwood
GERD
IW-3718
3 Plausible Buyout Scenarios Within Biotech
Seeking Alpha
Tue, 07/5/16 - 10:20 am
biotech
Acadia
AstraZeneca
Allergan
Biogen
Teva Pharmaceutical
Biomarin
Incyte
Ironwood
Medivation
Pfizer
Relypsa
Synergy Pharmaceuticals
M&A
3 Big Battles Brewing in Biotech
Motley Fool
Sun, 04/10/16 - 01:50 pm
AstraZeneca
ZS-9
Relypsa
Veltassa
Synergy Pharmaceuticals
plecanatide
Linzess
Ironwood
Allergan
Incyte
Eli Lilly
baricitinib
AbbVie
Humira
Ironwood steps up to challenge Valeant with Allergan's IBS med Viberzi
Fierce Pharma Marketing
Wed, 08/12/15 - 09:09 am
Valeant Pharmaceuticals
Ironwood
Allergan
IBS
Viberzi
Does Synergy Pharma's Plecanatide Blow Away The Competition?
Seeking Alpha
Fri, 07/17/15 - 10:08 am
Synergy Pharmaceuticals
IBS-C
plecanatide
Linzess
Ironwood
AstraZeneca, Ironwood to seek Chinese approval for linaclotide following positive results in late-stage IBS-C trial
First Word Pharma
Wed, 07/8/15 - 09:53 am
AstraZeneca
Ironwood
China
linaclotide
IBS-C
Next DTC push for Linzess: Spotlight patients, with big salesforce backup
Fierce Pharma Marketing
Thu, 04/9/15 - 10:02 am
Actavis
Ironwood
DTC
Linzess
IBS-C
Key Pharmaceutical Stocks Ready to Deliver Earnings Beats
Yahoo/Zacks.com
Thu, 01/16/14 - 11:44 am
earnings
Forest Labs
JNJ
Ironwood
The Best- And Worst-Performing Biotech Stocks July 19 To July 26
Forbes
Mon, 07/29/13 - 12:27 pm
TearLab
Array Biopharma
Furiex Pharmaceuticals
InterMune
Prosensa
Boston Scientific
Orexigen
Momenta
Ironwood
INSYS Therapeutics
Sequenom
OncoMed
Abraxis
Sarepta
Epizyme
Tesaro
Synta Pharmaceuticals
Bluebird Bio
Exelixis
Lexicon Pharmaceuticals
Intercept Pharma
GTx
The Compelling Science Behind Synergy
Seeking Alpha
Mon, 04/29/13 - 11:33 am
Synergy Pharmaceuticals
plecanatide
Ironwood
Linzess
Ironwood's Bowel Drug Sales Disappoint
TheStreet.com
Tue, 04/23/13 - 10:47 am
Ironwood
Linzess
Forest Labs
irritable bowel syndrome
IBS
Synergy Pharmaceutical Could Almost Double In Value With Plecanatide
Seeking Alpha
Thu, 10/25/12 - 11:09 am
plecanatide
Synergy Pharmaceuticals
Ironwood
Ironwood Implies Upside For Synergy; Lessons Learned From Dendreon
Seeking Alpha
Thu, 10/25/12 - 11:03 am
Ironwood
Dendreon
Synergy Pharmaceuticals
Forest Labs
Novartis
IBS-C
linaclotide

Pages